{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:59:43Z","timestamp":1772751583350,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,11,25]],"date-time":"2005-11-25T00:00:00Z","timestamp":1132876800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s10456-005-9018-5","type":"journal-article","created":{"date-parts":[[2005,11,24]],"date-time":"2005-11-24T13:44:17Z","timestamp":1132839857000},"page":"229-238","source":"Crossref","is-referenced-by-count":27,"title":["The inhibition of angiogenesis by antisense oligonucleotides to clusterin"],"prefix":"10.1007","volume":"8","author":[{"given":"John K.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin E.","family":"Gleave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Gleave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen M.","family":"Burt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,11,25]]},"reference":[{"key":"9018_CR1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0169-5002(03)00147-8","volume":"41","author":"RA Stahel","year":"2003","unstructured":"Stahel RA, Zangemeister-Witte U. (2003). Antisense oligonucleotides for cancer therapy \u2013 an overview. Lung Cancer 41:581\u2013588","journal-title":"Lung Cancer"},{"key":"9018_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2004.06.054","volume":"498","author":"A El-Aneed","year":"2004","unstructured":"El-Aneed A. (2004). Current strategies in cancer therapy. European Journal of Pharmacology 498:1\u20138","journal-title":"Eur J Pharmacol"},{"issue":"2 Suppl 1","key":"9018_CR3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0090-4295(01)01241-9","volume":"58","author":"ME Gleave","year":"2001","unstructured":"Gleave ME, Miyake H, Zellweger T et\u00a0al. (2001). Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin\/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer. Urology 58(2 Suppl 1):39\u201349","journal-title":"Urology"},{"issue":"4","key":"9018_CR4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/sj.neo.7900174","volume":"3","author":"T Zellweger","year":"2001","unstructured":"Zellweger T, Miyake H, July LV. (2001). Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin. Neoplasia 3(4): 360\u20137","journal-title":"Neoplasia"},{"issue":"12","key":"9018_CR5","first-page":"4245","volume":"7","author":"H Miyake","year":"2001","unstructured":"Miyake H, Hara I, Kamidono S et\u00a0al. (2001). Synergistic chemsensitization and inhibition of tumor growth and metastasis by the antisense oligonucleotide targeting clusterin gene in a human bladder cancer model. Clin Cancer Res 7(12):4245\u20134252","journal-title":"Clin Cancer Res"},{"issue":"3","key":"9018_CR6","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0022-3565(24)29459-3","volume":"298","author":"T Zellweger","year":"2001","unstructured":"Zellweger T, Miyake H, July LV et\u00a0al. (2001). Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2\u2019-O-(2-methoxy)ethyl chemistry. J Pharmacol Exp Ther 298(3): 934\u201340","journal-title":"J Pharmacol Exp Ther"},{"key":"9018_CR7","doi-asserted-by":"crossref","first-page":"8441","DOI":"10.1038\/sj.onc.1206999","volume":"22","author":"D Del Bufalo","year":"2003","unstructured":"Del Bufalo D, Trisciuciuoglio D, Scarsella M, Zangemeister-Witte U, Zupi G. (2003). Treatment of melanoma cells with a bcl-2\/bcl-xL antisense oligonucleotide induces antiangiogenic activity. Oncogene 22:8441\u20138447","journal-title":"Oncogene"},{"issue":"10","key":"9018_CR8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.tips.2004.08.003","volume":"25","author":"SP Henry","year":"2004","unstructured":"Henry SP, Marcusson EG, Vincent TM, Dean NM. (2004). Settings sights on the treatment of ocular angiogenesis using antisense oligonucleotides. Trends in Pharmacological Sciences 25(10):523\u2013527","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"9018_CR9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1001\/archopht.123.2.214","volume":"123","author":"RB Bhisitkul","year":"2005","unstructured":"Bhisitkul RB, Robinson GS, Moulton RS, Claffey KP, Gragoudas ES, Millar MD. (2005). Arch. Ophthalmol 123(2): 214\u2013219","journal-title":"Arch Ophthalmol"},{"key":"9018_CR10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1442-9071.2005.00952.x","volume":"33","author":"RJ Marano","year":"2005","unstructured":"Marano RJ, Rakoczy PE. (2005). Treatments for choroidal and retinal neovascularization: a focus on oligonucleotide therapy and delivery for the regulation of gene function. Clinical and Experimental Ophthamology 33:81\u201389","journal-title":"Clin Exp Ophthamol"},{"issue":"6","key":"9018_CR11","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/S0002-9440(10)63267-1","volume":"165","author":"B Kim","year":"2004","unstructured":"Kim B, Tang Q, Biswas PS, Schifflers RM, Xie FY, Ansari AM, Scaria PV, Woodle MC, Lu P, Rouse BT. (2004). Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am. J. Pathol. 165(6):2177\u20132185","journal-title":"Am J Pathol"},{"key":"9018_CR12","doi-asserted-by":"crossref","first-page":"7714","DOI":"10.1016\/S0021-9258(18)32238-5","volume":"12","author":"O Blaschuk","year":"1983","unstructured":"Blaschuk O, Burdzy K, Fritz IB. (1983). Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid. J Biol Chem 12:7714\u20137720","journal-title":"J Biol Chem"},{"issue":"7","key":"9018_CR13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/1357-2725(95)00027-M","volume":"27","author":"ME Rosenberg","year":"1995","unstructured":"Rosenberg ME, Silkensen J. (1995). Clusterin: Physiologic and pathophysiologic considerations. Int J Biochem Cell Biol 27(7):633\u2013645","journal-title":"Int J Biochem Cell Biol"},{"key":"9018_CR14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/pros.10047","volume":"50","author":"LV July","year":"2002","unstructured":"July LV, Akbari M, Zellweger T et\u00a0al. (2002). Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy. The Prostate 50:179\u2013188","journal-title":"The Prostate"},{"issue":"2","key":"9018_CR15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1015694802521","volume":"20","author":"ME Gleave","year":"2002","unstructured":"Gleave ME, Zellweger T, Chi K et\u00a0al. (2002). Targeting anti-apoptotic genes upregulated by androgen withdrawl using antisense oligonucleotides to enhance androgen- and chemo-sensitivity in prostate cancer. Invest New Drugs 20(2):145\u201358","journal-title":"Invest New Drugs Am of Pathol"},{"key":"9018_CR16","doi-asserted-by":"crossref","unstructured":"Redondo M, Villar E, Torres-Munoz J et\u00a0al. Overexpression of clusterin in human breast carcinoma. Am J Pathol 2000; 157(2): 393\u20139","DOI":"10.1016\/S0002-9440(10)64552-X"},{"key":"9018_CR17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/1097-0045(2000)45:9+<21::AID-PROS5>3.0.CO;2-C","volume":"9","author":"C Lee","year":"2000","unstructured":"Lee C, Janulis L, Ilio K et\u00a0al. (2000). In vitro models of prostate apoptosis: clusterin as an antiapoptotic mediator. Prostate Suppl 9:21\u20134","journal-title":"Prostate Suppl"},{"issue":"28","key":"9018_CR18","doi-asserted-by":"crossref","first-page":"21055","DOI":"10.1074\/jbc.M002055200","volume":"275","author":"M Cervellera","year":"2000","unstructured":"Cervellera M, Raschella G, Santilli G et\u00a0al. (2000). Direct transactivation of the anti-apoptotic gene apopliprotein J (clusterin) by B-MYB. J Biol Chem 275(28):21055\u201360","journal-title":"J Biol Chem"},{"issue":"3","key":"9018_CR19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1523-1747.1999.00531.x","volume":"112","author":"I Viard","year":"1999","unstructured":"Viard I, Wherli P, Jornot L et\u00a0al. (1999). Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J Invest Dermatol 112(3):290\u20136","journal-title":"J Invest Dermatol"},{"issue":"8","key":"9018_CR20","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/sj.bjp.0703660","volume":"131","author":"M Artwohl","year":"2000","unstructured":"Artwohl M, Holzenbeinn T, Wagner L, Freudenthaler A, Waldhausl W, Baumgartner-Parzer SM. (2000). Levamisole induced apoptosis in cultured vascular endothelial cells. Br J Pharmacol 131(8):1577\u20131583","journal-title":"Br J Pharmacol"},{"issue":"9","key":"9018_CR21","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1172\/JCI9037","volume":"106","author":"L McLaughlin","year":"2000","unstructured":"McLaughlin L, Zhu G, Mistry M, Ley-Ebert C, Stuart WD, Florio CJ, Groen PA, Witt SA, Kimball TR, Witte DP, Harmony JAK, Aronow BJ. (2000). Apolipoprotein J\/clusterin limits the severity of murine autoimmune myocarditis. J. Clin. Invest. 106(9):1105\u20131113","journal-title":"J Clin Invest"},{"key":"9018_CR22","first-page":"1971","volume":"148","author":"DK Swertfeger","year":"1996","unstructured":"Swertfeger DK, Witte DP, Stuart WD, Rockman HA, Harmony JA. (1996). Apolipoprotein J\/clusterin induction in myocarditis: A localized response gene to myocardial injury. Am. J. Pathol. 148:1971\u20131983","journal-title":"Am J Pathol"},{"key":"9018_CR23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/(SICI)1097-4652(199903)178:3<359::AID-JCP10>3.0.CO;2-O","volume":"178","author":"MJ Pollman","year":"1999","unstructured":"Pollman MJ, Naumovski L, Gibbons GH. (1999). Endothelial cell apoptosis in capillary network remodeling. Journal of Cellular Physiology 178: 359\u2013370","journal-title":"J Cell Physiol"},{"issue":"2","key":"9018_CR24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1089\/1545457041526290","volume":"14","author":"V Noe","year":"2004","unstructured":"Noe V, Lavarino C, Adan J, Rivas M, Lopez-Matas M, Pagan R, Mitjans F, Vilaro S, Piulats J, Ciudad CJ. (2004). Use of siRNAs and antisense oligonucleotides against surviving RNA to inhibit steps leading to tumor angiogenesis. Oligonucleotides 14 (2):100\u2013113","journal-title":"Oligonucleotides"},{"key":"9018_CR25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.lab.2004.04.009","volume":"144","author":"A Hida","year":"2004","unstructured":"25. Hida A, Kawakami A, Miyashita T, Yamasaki S, Nakashima K, Tanaka F, Izumi Y, Tamai M, Huang M, Ida H, Nakamura H, Origuchi T, Ueki Y, Eguchi K. (2004). Nitric oxide acts on the mitochondria and protects human endothelial cells from apoptosis. J. Lab. Clin. Med. 144:148\u2013155","journal-title":"J Lab Clin Med"},{"issue":"5","key":"9018_CR26","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0959-8049(97)10145-9","volume":"34","author":"G Fontanini","year":"1998","unstructured":"Fontanini G, Boldrini L, Vignati S, Chine S, Basolo F, Silvestri V, Lucch M, Mussi A, Angeletti CA, Bevilacqua G. (1998). Bcl2 and p53 regulate vascular endothelial growth factor (VEGF) mediated angiogenesis in non-small cell lung carcinoma. Eur J. Cancer 34(5):718\u2013723","journal-title":"Eur J Cancer"},{"key":"9018_CR27","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/(SICI)1097-0215(20000515)86:4<570::AID-IJC20>3.0.CO;2-T","volume":"86","author":"SH Leech","year":"2000","unstructured":"Leech SH, Olie RA, Gautschi O. (2000). Induction of apoptosis in lung cancer cells flowing bcl-xl antisense treatment. Int. J. Cancer. 86:570\u2013576","journal-title":"Int J Cancer"},{"key":"9018_CR28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/A:1020543004400","volume":"76","author":"A Simoes-Wust","year":"2002","unstructured":"Simoes-Wust A, Schurpf T, Hall J, Stahel RA, Zangemeister-Witte U. (2002). Bcl-2\/bcl-xl bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide. Breast Cancer Res. Treat. 76:157\u2013166","journal-title":"Breast Cancer Res Treat"},{"issue":"16","key":"9018_CR29","doi-asserted-by":"crossref","first-page":"11245","DOI":"10.1074\/jbc.274.16.11245","volume":"274","author":"EJ Ackermann","year":"1999","unstructured":"Ackermann EJ, Taylor JK, Narayama R, Bennett CF. (1999). The role of antiapoptotic bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides. J. Biol. Chem. 274(16):11245\u201311252","journal-title":"J Biol Chem"},{"key":"9018_CR30","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/15079","volume":"17","author":"JK Taylor","year":"1999","unstructured":"30. Taylor JK, Zhang QQ, Wyatt JR, Dean NM. (1999). Induction of endogenous bcl-xs through the control of bcl-x pre-mRNA splicing by antisense oligonucleotides. Nat. Biotechnol. 17:1097\u20131100","journal-title":"Nat Biotechnol"},{"key":"9018_CR31","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/(SICI)1097-0215(20000615)86:6<855::AID-IJC15>3.0.CO;2-8","volume":"86","author":"H Miyake","year":"2000","unstructured":"Miyake H, Monia BP, Gleave ME. (2000). Inhibition of progression to androgen-independence by combined adjuvant treatment with antisense bcl-xl and antisense bcl-2 oligonucleotides plus taxol after castration in the Shinogi tumor model. Int. J. Cancer. 86:855\u2013862","journal-title":"Int. J. Cancer"},{"key":"9018_CR32","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1067\/msy.2001.115823","volume":"130","author":"N Sivamurthy","year":"2001","unstructured":"Sivamurthy N, Stone DH, Logerfo FW, Quist WC. (2001). Apolipoprotien J inhibits the migration and adhesion of endothelial cells. Surgery 130:204\u2013209","journal-title":"Surgery"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-005-9018-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10456-005-9018-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-005-9018-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T22:32:37Z","timestamp":1736116357000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10456-005-9018-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,25]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["9018"],"URL":"https:\/\/doi.org\/10.1007\/s10456-005-9018-5","relation":{},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,25]]}}}